Literature DB >> 3906488

Lymphoid tumors of the ocular adnexa. Clinical correlation with the working formulation classification and immunoperoxidase staining of paraffin sections.

J H Ellis, P M Banks, R J Campbell, T J Liesegang.   

Abstract

Eighty-eight patients with ocular adnexal lymphoid lesions examined at the Mayo Clinic between 1970 and 1982 were evaluated. The histopathologic type was reclassified using the working formulation. Paraffin sections were evaluated with immunoperoxidase staining. There were 11 "pseudotumors" and 77 lymphomas. Sixty lymphomas were small lymphocytic type A; 27 tissues had a monoclonal staining pattern, and 4 had a polyclonal staining pattern. Five of the pseudotumors had a polyclonal staining pattern; none had a monoclonal pattern. The remainder did not stain or tissue was not available. Thirty-six of the 44 lymphomas that presented in the ocular adnexa remained localized. There were no distinguishing features between conjunctival and orbital lymphomas. Significant damage to the ocular tissue occurred in 15 of the 63 patients treated with radiation therapy. Older, asymptomatic patients with a favorable histologic type may not require treatment; therapy is reserved for specific indications. The probability of survival to five or seven years differs little from that expected in the general population.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3906488

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  15 in total

1.  Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European and American Lymphoma.

Authors:  C Auw-Haedrich; S E Coupland; A Kapp; A Schmitt-Gräff; R Buchen; H Witschel
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

2.  [Sudden appearance of conjunctival tumor in a 7-year-old boy].

Authors:  E Domeier; R Büttner; F G Holz; K U Löffler
Journal:  Ophthalmologe       Date:  2006-07       Impact factor: 1.059

3.  Primary mantle cell lymphoma of the conjunctiva: a case report.

Authors:  Miltiadis Aspiotis; Spiridon Gorezis; Ioannis Asproudis; Elena Tsanou; Evangelos Papadiotis; Sevasti Kamina; Niki J Agnantis; Maria Bai
Journal:  Virchows Arch       Date:  2006-09-13       Impact factor: 4.064

4.  Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases.

Authors:  Frédéric Charlotte; Kamal Doghmi; Nathalie Cassoux; Hongtao Ye; Ming-Qing Du; Michèle Kujas; Annette Lesot; George Mansour; Phuc Lehoang; Nicole Vignot; Frédérique Capron; Véronique Leblond
Journal:  Virchows Arch       Date:  2005-12-02       Impact factor: 4.064

5.  Malignant lymphoma of the conjunctiva following Hodgkin's disease.

Authors:  H E Grossniklaus; D C Farhi; B R Jacobson; M F Abbuhl
Journal:  Br J Ophthalmol       Date:  1988-03       Impact factor: 4.638

6.  The cytological, immunocytochemical and molecular genetic analysis in diagnosis of the neoplasms of the eye, eye adnexa and orbit.

Authors:  Z Krzystolik; A Rosławska; E Bedner
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

7.  Ocular adnexal lymphoma-comparison of MALT lymphoma with other histological types.

Authors:  M Cahill; C Barnes; P Moriarty; P Daly; S Kennedy
Journal:  Br J Ophthalmol       Date:  1999-06       Impact factor: 4.638

8.  Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients.

Authors:  Soley Bayraktar; Ulas D Bayraktar; Alexandra Stefanovic; Izidore S Lossos
Journal:  Br J Haematol       Date:  2010-11-18       Impact factor: 6.998

9.  The clinical characteristics and treatment results of ocular adnexal lymphoma.

Authors:  Jung-Min Woo; Chien-Kue Tang; Mee-Sook Rho; Jin-Hwa Lee; Hyuk-Chan Kwon; Hee-Bae Ahn
Journal:  Korean J Ophthalmol       Date:  2006-03

10.  Ocular adnexal lymphoma in the Northeast Indian population.

Authors:  Dipankar Das; Panna Deka; Kasturi Bhattacharjee; Jayanta Kumar Das; Ganesh Kuri; Akshay Chandra Deka; Harsha Bhattacharjee
Journal:  Indian J Ophthalmol       Date:  2008 Mar-Apr       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.